Y-27632 (Y27632)是一种可口服的、ATP竞争性的ROCK的选择性抑制剂，是一种高效的、细胞可渗透的、可逆的、选择性的Rho相关蛋白激酶抑制剂，p160ROCK的K_i值为140 nM。

参考文献

1. Xue ZW, et al. Rho-associated coiled kinase inhibitor Y-27632 promotes neuronal-like differentiation of adult human adipose tissue-derived stem cells. Chin Med J (Engl). 2012 Sep;125(18):3332-5.
2. Inan S, et al. Antiepileptic effects of two Rho-kinase inhibitors, Y-27632 and fasudil, in mice. Br J Pharmacol. 2008 Sep;155(1):44-51.
3. Bito H, et al. A critical role for a Rho-associated kinase, p160ROCK, in determining axon outgrowth in mammalian CNS neurons. Neuron. 2000 May;26(2):431-41.
4. Isler D, et al. Antitumoral effect of a selective Rho-kinase inhibitor Y-27632 against Ehrlich ascites carcinoma in mice. Pharmacol Rep. 2014 Feb;66(1):114-20.

客户使用本产品发表的科研文献（部分）

[1] Li H, Zhang C, Hu Y, et al. A reversible shearing DNA probe for visualizing mechanically strong receptors in living cells. Nat Cell Bio. 2021 Jun;23(6):642-651. IF: 28.824

冰袋运输。粉末直接保存于-20℃，有效期2年。建议分装后-20℃干燥保存，避免反复冻融。